• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Tuesday, May 25, 2021

    Offline Date

    Wednesday, November 24, 2021

    ACPE Expiration Date

    Saturday, May 18, 2024

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Nearly 50 million people worldwide live with dementia, and of those, up to 90% will experience Behavioral and Psychological Symptoms of Dementia (BPSD), including psychosis, during their disease progression. Psychotic symptoms of dementia include hallucinations, delusions, and delusional misidentifications. These symptoms decrease patients’ quality of life and are often distressing for patients and caregivers. Management of psychosis in dementia can be challenging and requires a comprehensive pharmacologic and non-pharmacologic approach. Pharmacologic management is complicated by a lack of approved medications for this indication and marked by low efficacy and high risk of adverse effects for the agents normally employed. This educational activity will educate pharmacists and nurses on the types and causes of dementia-related psychosis (DRP) and how to recognize DRP in the older adult population. This activity will educate pharmacists and nurses on the proper use of treatments for DRP, with a focus on the long-term care setting. This activity will also include discussion on emerging treatments for DRP, as this remains an area of high need. Clinical data about agents currently being studied for DRP will be presented and discussed to give learners the most up-to-date view of the treatment landscape.

      Handouts

      • Slide Document :   21029H01_2pp.pdf
      • Slide Document :   21029H01_6pp.pdf

      Financial Support By

      Acadia Pharmaceuticals, Inc.
    • Pharmacist

      Differentiate between types and causes of dementia-related psychosis (DRP).
      Compare and contrast treatments for DRP, including non-pharmacological and current pharmacological treatments.
      Examine clinical data for agents being studied for the treatment of DRP.

      Nurse

      Compare and contrast treatments for DRP, including non-pharmacological and current pharmacological treatments.
      Differentiate between types and causes of dementia-related psychosis (DRP).
      Examine clinical data for agents being studied for the treatment of DRP.
    • Activity Type

      Application

      CE Broker

      20-816344

      Universal Activity Number

      Pharmacist 0798-0000-21-029-H01-P
      Nurse 0798-0000-21-029-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).